Brian M. Silver, Chief Financial Officer at TScan Therapeutics, Inc. (TCRX), bought 6,000 shares at $1.50 ($9K) on 2022-12-27, disclosed to the SEC on 2022-12-29.
Open-market purchase of $9k TCRX by Chief Financial Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Clearly above the average filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.50 | 2,842 | $4K | 46.4% |
| 2 | $1.56 | 3,158 | $5K | 53.6% |
| Total | $1.53 avg | 6,000 | $9K | 100% |
| Filing → |
| TCRX | BUY | 2021-09-13 | $50K | — | Filing → |
| TCRX | BUY | 2021-07-22 | $15K | — | Filing → |